Loading organizations...
Hemi Health is a digital-first specialty care platform based in Frederiksberg, Denmark, focused on diagnosing and treating headaches and migraines through an optimized digital experience combined with clinical expertise. The company aims to revolutionize headache treatment, addressing a global health challenge affecting 1.3 billion people, particularly for those aged 15-49 where migraines are the leading cause of disability. As of February 2026, Hemi Health has raised €4 million in seed funding to support its international expansion plans, operating with a team of 1-10 employees. Its B2C digital healthcare platform combines a user-centric digital experience with specialized clinical care delivery, primarily targeting migraine and concussion care patients. Established in 2023, Hemi Health was founded by Benedicte Grytte Dahl, Anna Løfqvist, Sune K-Holm Nielsen, and Mathias Iversen.
Hemi Health has raised $4.7M across 1 funding round.
Hemi Health has raised $4.7M in total across 1 funding round.
Hemi Health has raised $4.7M across 1 funding round. Most recently, it raised $4.7M Seed in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 20, 2026 | $4.7M Seed | Claudia Colciago, PHD, SwissHealth Ventures | Alliance Venture, Crowberry Capital, Sondo | Announced |
Hemi Health has raised $4.7M in total across 1 funding round.
Hemi Health's investors include Claudia Colciago, PhD, SwissHealth Ventures, Alliance Venture, Crowberry Capital, Sondo.
